"Designing Growth Strategies is in our DNA"

Spirometer Market Size, Share & COVID-19 Impact Analysis, By Product Type (Devices, Software, and Accessories & Consumables), By Type (Volume Measurement and Peak Flow Meters), By Application (Chronic Obstructive Pulmonary Disorder (COPD), Asthma, and Others), By End User (Hospitals, Diagnostic Centers, Homecare Settings, Physician/Primary Care Offices or Clinics, and Other Facilities), and Regional Forecast, 2023-2030

Region : Global | Format: PDF | Report ID: FBI100486

 

KEY MARKET INSIGHTS

Play Audio Listen to Audio Version

The spirometer market size was valued at USD 583.2 million in 2022 and is projected to grow from USD 613.3 million in 2023 to USD 891.5 million by 2030, exhibiting a CAGR of 5.5% during the forecast period (2023-2030). North America accounted for a market value of USD 293.0 million in 2022. The spirometer is a diagnostic device used for measuring the air volume inspired and expired by the lungs. It is used to diagnose asthma, chronic obstructive pulmonary disease (COPD), and other conditions that affect breathing. Spirometry is the basic lung function test required to diagnose and treat COPD, asthma, and other respiratory disorders. 


According to the Forum of International Respiratory Societies (FIRS) 2023 statistics, chronic respiratory diseases cause an immense worldwide health burden. It has been estimated that around 334 million people have asthma, while more than 65 million people suffer from COPD. In addition, asthma is the most common cause of respiratory illness, affecting 14% of children globally and number is rising.


Moreover, public and private organizations are collaborating to develop devices for managing and diagnosing respiratory diseases such as COPD and asthma. In addition, the market players are actively investing in introducing technologically advanced devices and software to surge the demand for these products. For instance, in January 2023, Aluna completed a USD 15.3 million Series B round of financing to continue the growth of its solution, which is a spirometer device and easy-to-use app for managing asthma, cystic fibrosis, and COPD.


COVID-19 IMPACT


Disruptions in Supply Chain of Medical Devices Hindered the Market Growth


The COVID-19 outbreak impacted the global market negatively, owing to a decline in the diagnosis and treatment of respiratory diseases. In addition, the majority of pulmonary function tests (PFTs) labs and testing centers were closed in the potentially affected areas. The pandemic also disrupted the supply chain of medical devices worldwide. For instance, some major global players witnessed supply disruptions, especially from distributors in China. Meanwhile, certain players were impacted due to the lack of locally sourced raw materials or parts.



  • For instance, Vitalograph, one of the manufacturers of spirometry devices based in Ireland, faced production issues since some of the parts were procured from China. Considering various factors associated with the regional spread of COVID-19, the market experienced a decline in its growth in 2020.


In 2021, as the lockdown restrictions were eased with the resumption of healthcare facilities, the supply of these devices witnessed a surge at the global level. This impact was also observed on the revenue of the market players operating in the market.



  • According to the 2021 annual report of Geratherm Medical AG, the respiratory business segment witnessed a growth of 15.6% in 2021 from the previous year. The segment focuses on developing, producing, and marketing products such as spirometers designed for cardiopulmonary function testing.

  • This growth continued in 2022 as the sales of medical devices for lung function measurement increased in the first nine months by 6.0%


Moreover, the market is anticipated to grow steadily during the forecast period, owing to increased test volume measurement and demand for these devices.


LATEST TRENDS


Growing Investment Opportunities to Drive Market Growth


Owing to the growing demand for accurate devices for lung function assessment, the major players are focusing on investments to develop advanced devices. Various established players and new start-ups seek funding to carry out research and hospital and clinical testing of pulmonary testers.



  • For instance, In June 2021, NuvoAir, a Stockholm-based digital health company, raised USD 12 million to expand its chronic disease management and clinical trial platforms. The funding was directed by AlbionVC and comes on the back of a record 500% growth for the first quarter of 2021. The platform's technologies comprise Bluetooth-enabled spirometers that can be used to monitor lung function remotely, a sensor connected to asthma and COPD inhalers, and Fitbit integration.


Moreover, government and private organizations such as the National Science Foundation and the European Union Horizon Program are actively collaborating with research institutes and start-ups to develop devices for the management and diagnosis of respiratory diseases such as COPD and asthma.



  • For instance, in July 2020, NanoVation, a start-up company involved in developing devices for COPD patients, received a grant worth USD 2.0 million from the European Union’s Horizon 2020 EIC Accelerator program for their SenseGuard device. This device is based on nano-sensor technology, which is wearable and used to monitor patients' breathing continuously. Such initiatives by the industry players are anticipated to boost the spirometer market growth.


Request a Free sample to learn more about this report.


DRIVING FACTORS


Increasing Technological Advancement in Diagnostic Tools to Proliferate Market Growth


Lung function tests are essential to evaluate the core functioning of the lungs. By assessing PFTs, which include lung volumes, lung capacities, rates of flow, and gas exchange, physicians get the information that aids in diagnosing multiple lung disorders, especially COPD. High investments by the key market players for the extensive research and development of novel and advanced diagnostic and monitoring technologies are expected to enable the early diagnosis of COPD. Thus, technological developments are expected to have a huge impact on the market.


The underutilization of pulmonary function tests has been overcome by developing portable, hand-held, and user-friendly spirometry devices. For instance, in January 2020, NuvoAir’s connected spirometer received U.S. FDA approval for sale across the country. The device is designed for indications such as COPD, asthma, and cystic fibrosis. Thus, constant innovations are one of the growth factors responsible for driving the market growth.


Rising Prevalence of COPD to Propel Product Sales


COPD is the third leading cause of death globally and presents a significant burden on patients and health services. According to an article published by the National Heart, Lung, and Blood Institute in March 2022, COPD is the leading cause of death in the U.S., affecting about 16 million Americans. The major risk factor for COPD includes tobacco smoking. However, other environmental exposures, such as air pollution and biomass fuel exposure, may also contribute to severe health implications. The increasing prevalence of the disorder is an alarming situation worldwide that is expected to propel the demand for diagnostic devices during the forecast period.


RESTRAINING FACTORS


Dearth of Skilled Professionals May Limit Device Adoption


Despite the high prevalence of asthma and COPD globally, certain factors limit the adoption of these devices. Among them, the lack of a skilled workforce for conducting diagnostic tests is anticipated to restrain market growth. Pulmonary function testing is a series of different breathing tests that trained pulmonary function technologists can lead. However, there is a shortage of skilled healthcare professionals in developing countries. The immigration of healthcare workers to developed countries is the main reason for this shortage. The tendency to migrate to higher economic countries is primarily owing to the search for better wages and working conditions.


According to an article published by the World Health Organization (WHO) in July 2023, it is estimated that there will be a shortfall of 10 million health workers by 2030, especially in low-and lower-middle-income countries. This, coupled with other factors, such as the closure of PFT labs and diagnostic centers during the COVID-19 outbreak and limited awareness in underdeveloped countries, is anticipated to hamper the market growth.


SEGMENTATION


By Product Type Analysis


Higher Adoption of Devices Due to Rising Need for Diagnostic Test Led to its Dominance


On the basis of product type, the market is divided into devices, software, and accessories & consumables.


The global market is witnessing significant technological advancements with an aim to improve testing capabilities, which has led to an increased demand for advanced devices. Moreover, start-ups and key players have started investing in the market to develop devices for effective management of respiratory diseases which led to dominance of devices segment. For example, in January 2023, Aluna, a company focused on developing solutions for asthma management, received USD 15.3 million in Series B funding to continue growing its solution among doctors and patients managing asthma, cystic fibrosis, and COPD. This is expected to increase the spirometry devices' product sales and market value.


The software segment is anticipated to showcase significant growth during the forecast period due to the launch of advanced software solutions to manage testing procedures. Furthermore, due to the COVID-19 pandemic, the customer base has approached the online platform to manage spirometry testing, thus expanding the size of the software segment.


The accessories & consumables segment is anticipated to have a considerable share in the market during the forecast period owing to the reusability of the devices, leading to higher demand for accessories such as tubes, syringes, and filters.


By Type Analysis


Volume Measurement Segment Dominated due to Capability of Producing Accurate Results


On the basis of type, the market is segmented into volume measurement and peak flow meters.


The volume measurement segment held a dominant share in the market in 2022. The dominance can be attributed to its characteristic of producing accurate results with ease of handling the device. The volume measurement segment is projected to register a higher CAGR than peak flow meters during the forecast period due to the increasing application of the devices in asthma, cystic fibrosis, and others. In addition, the high adoption of spirometry devices for volume measurements has led to increased product sales.


To know how our report can help streamline your business, Speak to Analyst


The peak flow meters segment is expected to grow at a significant CAGR during the forecast period due to the increasing number of market players engaged in introducing advanced devices such as wireless spirometers in the global market. For example, in March 2021, DKSH Business Unit Healthcare and Smart Respiratory Products, a London-based digital healthcare company, announced a strategic collaboration to bring Smart Peak Flow, a compact digital peak expiratory flow meter (PEFM), to asthmatic patients in Asia.


By Application Analysis


Growing Occurrence of Chronic Obstructive Pulmonary Disorder to Foster Segment Growth


Based on application, the market is segmented into chronic obstructive pulmonary disorder (COPD), asthma, and others.


The high prevalence of COPD globally and the increasing incidence of pulmonary infection among patients are some of the major factors responsible for the COPD segment dominance in 2022 According to a study published by the Thorax Journal in March 2021, individuals with exposure to inhalation of high doses of pesticides have a higher incidence of respiratory symptoms, airway obstruction, and COPD.


These devices are now being tested in labs to widen their application for cystic fibrosis and other pulmonary disorders. This factor is expected to contribute to the growth of the others segment during the forecast period.


By End User Analysis


Hospital Segment to Dominate Owing to Increasing Healthcare Expenditure


In terms of end user, the market is segmented into hospitals, diagnostic centers, homecare settings, physician/primary care offices or clinics, and other facilities.


The hospitals segment is set to dominate the global spirometer market share during the forecast period. The dominance can be attributed to the increasing healthcare expenditure leading to the adoption of advanced pulmonary function testing devices. For example, the National Healthcare Expenditure in the U.S. grew by 2.7% to USD 4.3 trillion in 2021, and hospital expenditure grew by 4.4% to USD 1,323.9 billion in 2021.


The clinics segment is expected to grow at a significant CAGR during the forecast period due to the increase in the number of stand-alone respiratory clinics in developed and emerging countries.


The diagnostic centers segment recorded a considerable share in the market in 2022 owing to rising patient preference for having lung function tests at the nearby diagnostic center. This has leveraged the adoption of hand held devices by the centers, leading to higher sales.


During the unprecedented times of COVID-19, home healthcare was one of the best services available at the doorstep


The homecare settings segment is expected to register significant growth by the end of the forecast period due to patients' rising preference shift from hospital to homecare settings.


REGIONAL INSIGHTS


North America Spirometer Market Size, 2022 (USD Million)

To get more information on the regional analysis of this market, Request a Free sample


North America dominated the global market with a share of 50.24% in 2022. The dominance of this region can be attributed to the increasing prevalence of COPD, asthma, and other respiratory diseases. This has caused an increasing economic burden on the healthcare system, leading to development of precise devices to overcome the issue. For instance, as per the Global Initiative for Chronic Obstructive Lung Disease 2023 report, COPD is one of the top three causes of death worldwide, and 90% of these deaths occur in low and middle-income countries. The disease is exerting a huge burden on healthcare. For example, according to an article published by the American Family Physician in March 2023, asthma and COPD affect more than 40 million Americans and is the fourth leading cause of death in the U.S. The widespread occurrence of the disease is anticipated to surge demand for diagnostic devices. The presence of major players in the region has further contributed to the dominance of North America. This, along with the presence of adequate regulatory policies in the U.S. and Canada, is responsible for the region's dominance in the global market.


To know how our report can help streamline your business, Speak to Analyst


Europe market is projected to grow at a significant CAGR during the forecast period owing to the growing product approvals by healthcare bodies. Government bodies are taking initiatives to increase awareness about respiratory diseases to increase the number of patients undergoing diagnostic tests.


The Asia Pacific market is anticipated to showcase exponential growth during the forecast period owing to the increasing number of companies entering the untapped Asian economies. In addition, market players in this region are making heavy investments, which is expected to fuel demand for advanced products. For instance, in March 2021, VYAIRE launched AioCare, a remote mobile spirometer system in more than 15 countries including Australia.


Latin America and the Middle East & Africa regions accounted for a comparatively lower share than other regions in the market in 2022. However, many public and private organizations are introducing campaigns and training programs to upscale the count of skilled healthcare professionals for diagnostics. For instance, the Pan African Thoracic Society (PATS) has been building spirometry capacity through the training, mentorship, and technical support of 482 healthcare professionals across 13 African countries from 2017 to 2021.


KEY INDUSTRY PLAYERS


Increasing Focus on Technological Development by Major Companies to Strengthen Market Growth


The market is consolidated owing to the diverse product portfolio and remarkable distribution network of major companies in developed and emerging countries. Companies such as ndd Medizintechnik AG and COSMED srl, and others have introduced exemplary products in the market. However, the potential to leverage opportunities provided by the market is expected to enable the entry of several domestic players in the forthcoming years. Strategic partnerships among the key players to launch portable spirometers in the region are likely to contribute to the growth of the market. For instance, in January 2020, NuvoAir and Roche Italy partnered to manufacture portable devices for cystic fibrosis.


The other key players, such as MGC Diagnostics, Morgan Scientific, SCHILLER, VYAIRE Medical, and others, have also entered the market with novel advanced spirometry devices, software, and others.


LIST OF KEY COMPANIES PROFILED:



KEY INDUSTRY DEVELOPMENTS:



  • March 2023: Clario partnered with technology startup ArtiQ to integrate its AI into clinical trial data collection for spirometry.

  • January 2023: CAIRE Inc., an NGK SPARK PLUG CO., LTD. subsidiary, acquired MGC Diagnostics Holdings, Inc. (MGC) to strengthen its non-invasive cardiorespiratory diagnostics systems portfolio. MGC has a broad portfolio, which includes pulmonary function testing systems, cardiopulmonary exercise systems, spirometers, flow sensors, gas analyzers, and associated consumables.

  • August 2022: AstraZeneca India partnered with Alveofit, a SaaS-IoT-enabled respiratory healthcare platform. This partnership aims to offer IoT-enabled handheld spirometers at hospitals across India.

  • June 2021: ERT launched ERT iSpiro Virtual Visits, which enables real-time coaching during at-home pulmonary function tests (PFT). With iSpiro Virtual Visits, ERT delivers on its commitment to offer customer and patient-oriented innovations that enable decentralization.

  • September 2020: Midmark Corp. launched the Midmark Digital Spirometer, intended to make the detection and management of asthma, COPD, and other respiratory illnesses simple and effective.


REPORT COVERAGE


An Infographic Representation of Spirometers Market

To get information on various segments, share your queries with us



The research report provides a detailed analysis of the market and focuses on key aspects such as leading companies, product types, and leading product applications. Besides this, it offers insights into the market trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth of the advanced market over the recent years.


Report Scope & Segmentation






















































ATTRIBUTE



DETAILS



Study Period



2019-2030



Base Year



2022



Estimated Year



2023



Forecast Period



2023-2030



Historical Period



2019-2021



Growth Rate



CAGR of 5.5% from 2023 to 2030



Unit



Value (USD Million)



 


 


 


 


 


Segmentation



By Product Type



  • Devices

  • Software

  • Accessories & Consumables



By Type



  • Volume Measurement

  • Peak Flow Meters



By Application



  • Chronic Obstructive Pulmonary Disorder (COPD)

  • Asthma

  • Others



By End User



  • Hospitals

  • Diagnostic Centers

  • Homecare Settings

  • Physician/Primary Care Offices or Clinics

  • Other Facilities



By Region



  • North America (By Product Type, By Type, By Application, By End-User, By Country)


    • U.S. (By Type)

    • Canada (By Type)


  • Europe (By Product Type, By Type, By Application, By End-User, By Country/Sub-Region)


    • U.K. (By Type)

    • Germany (By Type)

    • France (By Type)

    • Italy (By Type)

    • Spain (By Type)

    • Scandinavia (By Type)

    • Rest of Europe (By Type)


  • Asia Pacific (By Product Type, By Type, By Application, By End User, By Country/Sub-Region)


    • Japan (By Type)

    • China (By Type)

    • India (By Type)

    • Australia (By Type)

    • Southeast Asia (By Type)

    • Rest of the Asia Pacific (By Type)


  • Latin America (By Product Type, By Type, By Application, By End User, By Country/Sub-Region)


    • Brazil (By Type)

    • Mexico (By Type)

    • Rest of Latin America (By Type)


  • Middle East & Africa (By Product Type, By Type, By Application, By End User, By Country/Sub-Region)


    • GCC (By Type)

    • South Africa (By Type)

    • Rest of the Middle East & Africa (By Type)







Frequently Asked Questions

Fortune Business Insights says that the global market size was valued at USD 583.2 million in 2022 and is projected to reach USD 891.5 million by 2030.

In 2022, the North America market size stood at USD 293.0 million.

Growing at a CAGR of 5.5%, the market is expected to exhibit steady growth during the forecast period (2023-2030).

The devices segment is expected to be the leading segment in this market during the forecast period.

Growing investments and funding opportunities coupled with increased spirometry test platforms are major factors driving the growth of the market.

ndd Medizintechnik AG, COSMED srl, MGC Diagnostics, and others are major players in the global market.

North America dominated the market share in 2022.

The launch of advanced technologies by market players, such as connected and portable product, are expected to drive the adoption in the global market.

Seeking Comprehensive Intelligence on Different Markets?
Get in Touch with Our Experts

Speak to an Expert
  • Nov, 2023
  • 2022
  • 2019-2021
  • 139

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Client Testimonials

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X